Colony Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $15.8M | Sell |
29,460
-2,605
| -8% | -$1.34M | 0.24% | 108 |
|
|
2023
Q2 | $15M | Buy |
32,065
+1,420
| +5% | +$596K | 0.21% | 121 |
|
|
2023
Q1 | $10.5M | Sell |
30,645
-2,745
| -8% | -$926K | 0.16% | 139 |
|
|
2022
Q4 | $12.2M | Buy |
33,390
+1,193
| +4% | +$423K | 0.17% | 135 |
|
|
2022
Q3 | $10.4M | Sell |
32,197
-1,557
| -5% | -$493K | 0.18% | 129 |
|
|
2022
Q2 | $10.9M | Buy |
33,754
+14,829
| +78% | +$4.45M | 0.19% | 123 |
|
|
2022
Q1 | $5.42M | Buy |
18,925
+10,423
| +123% | +$2.68M | 0.08% | 214 |
|
|
2021
Q4 | $2.35M | Buy |
8,502
+871
| +11% | +$221K | 0.04% | 308 |
|
|
2021
Q3 | $1.76M | Buy |
7,631
+507
| +7% | +$125K | 0.03% | 330 |
|
|
2021
Q2 | $1.64M | Buy |
7,124
+324
| +5% | +$65.1K | 0.03% | 322 |
|
|
2021
Q1 | $1.27M | Buy |
6,800
+919
| +16% | +$180K | 0.03% | 356 |
|
|
2020
Q4 | $993K | Buy |
5,881
+1,337
| +29% | +$200K | 0.02% | 372 |
|
|
2020
Q3 | $673K | Buy |
4,544
+133
| +3% | +$20.6K | 0.02% | 422 |
|
|
2020
Q2 | $724K | Sell |
4,411
-4,641
| -51% | -$712K | 0.02% | 392 |
|
|
2020
Q1 | $1.26M | Buy |
9,052
+6,081
| +205% | +$836K | 0.04% | 304 |
|
|
2019
Q4 | $390K | Buy |
2,971
+359
| +14% | +$41.6K | 0.01% | 574 |
|
|
2019
Q3 | $292K | Sell |
2,612
-4,381
| -63% | -$488K | 0.01% | 585 |
|
|
2019
Q2 | $775K | Buy |
6,993
+711
| +11% | +$83.7K | 0.02% | 424 |
|
|
2019
Q1 | $815K | Buy |
+6,282
| New | +$764K | 0.03% | 319 |
|
|
2018
Q2 | – | Sell |
-2,746
| Closed | -$212K | – | 515 |
|
|
2018
Q1 | $212K | Sell |
2,746
-404
| -13% | -$32.5K | 0.01% | 466 |
|
|
2017
Q4 | $266K | Buy |
+3,150
| New | +$268K | 0.02% | 407 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 458 |
|
|
2015
Q4 | $0 | Sell |
1
-114
| -99% | -$9.46K | ﹤0.01% | 849 |
|
|
2015
Q3 | $10K | Hold |
115
| – | – | ﹤0.01% | 612 |
|
|
2015
Q2 | $10K | Hold |
115
| – | – | ﹤0.01% | 596 |
|
|
2015
Q1 | $8K | Hold |
115
| – | – | ﹤0.01% | 594 |
|
|
2014
Q4 | $8K | Hold |
115
| – | – | ﹤0.01% | 604 |
|
|
2014
Q3 | $7K | Hold |
115
| – | – | ﹤0.01% | 655 |
|
|
2014
Q2 | $7K | Sell |
115
-1,074
| -90% | -$64.1K | ﹤0.01% | 578 |
|
|
2014
Q1 | $70K | Buy |
1,189
+299
| +34% | +$16.7K | 0.01% | 295 |
|
|
2013
Q4 | $45K | Buy |
+890
| New | +$44.6K | 0.01% | 331 |
|
Other funds holding LLY
Colony Group's LLY Position: Q3 2023 in Review
Colony Group reduced its Eli Lilly (LLY) stake by 8.1% in Q3 2023, selling an estimated $1.34M and leaving 29,460 shares worth $15.8M. The position accounts for 0.24% of the portfolio, ranked #108.
Colony Group first reported a position in LLY in Q4 2013 and has held it in 30 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Colony Group held 29,460 shares of Eli Lilly worth $15.8M as of Q3 2023.
- Colony Group sold 2,605 Eli Lilly shares in Q3 2023, an estimated $1.34M.
- Eli Lilly made up 0.24% of Colony Group's portfolio in Q3 2023, its #108 holding.
- Colony Group first reported a position in Eli Lilly in Q4 2013 and has held it in 30 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.